Registered Small Partnership Register of Legal Entities of Lithuania
LT

MB Suplemente

Reg. no. 307293092 VAT no. LT100019132819 Registered 17.07.2025 (1 year 4 months) NACE 47.73 Retail sale of pharmaceutical products · VDA, 26.08.2025 EVRK 477300 Retail sale of pharmaceutical products
Registered address Girdavos g. 26A, Vilnius m., Vilniaus miesto sav.
86/100
Risk score
Low risk
2 risk signals
Turnover
1 663 EUR
2025
Net profit
-1 530 EUR
2025

About the company

The company MB Suplemente (reg. no. 307293092) was registered on 17.07.2025. Registered address: Girdavos g. 26A, Vilnius m., Vilniaus miesto sav. Main industry: Wholesale and retail trade. In 2025, revenue was 1 663 EUR and profit -1 530 EUR. The company is a registered VAT payer. Regmio risk score: 86 out of 100 — low risk.

Frequently asked questions about MB Suplemente

When was MB Suplemente registered?

MB Suplemente was registered on 17.07.2025, registration number 307293092.

Is MB Suplemente active?

Yes, according to the register the company is active (not removed from the register).

What is the registered address of MB Suplemente?

Registered address: Girdavos g. 26A, Vilnius m., Vilniaus miesto sav.

Is MB Suplemente VAT registered?

Yes, VAT number: LT100019132819. Validity for cross-border transactions can be checked in EC VIES.

What does MB Suplemente do?

Main industry: Wholesale and retail trade.

What is the turnover of MB Suplemente?

In 2025, revenue was 1 663 EUR.

How many companies are registered at this address?

Registered in this building: 2 active companies.

Full profile available after login

Free account — 3 full profiles per month. Log in with an e-mail code, no password.

  • Board and authorised representatives
  • Owners and beneficial owners
  • Financial indicators 1
  • Tax and VAT
  • Legal events and restrictions
  • Timeline 5
Open full profile

Is this your company? Put the “Checked with Regmio” badge on your website or invoices. Get the badge · Add contacts

Data from official public registers · updated 20.11.2026. Data sources and disclaimer